Fusion Antibodies PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fusion Antibodies PLC with three other
miscellaneous service companies in Europe:
sales of £4.44 million [US$5.89 million]
Novus Group International Ab
(55.94 million Swedish Kronor [US$6.50 million]
Reneuron Group PLC
(£6.07 million [US$8.05 million]
of which 100%
was Development of cell-based therapies).
Fusion Antibodies PLC reported sales of £3.90 million (US$5.17 million)
March of 2020.
increase of 78.5%
versus 2019, when the company's sales were £2.18 million.